Avadel Pharmaceuticals plc (AVDL)
21.64
+0.01 (0.05%)
Inactive · Last trade price on Feb 11, 2026
Avadel Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Feb '26 Feb 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,124 | 2,115 | 1,013 | - | - | - | |
Market Cap Growth | 188.51% | 108.86% | - | - | - | - |
Enterprise Value | 2,070 | 2,061 | 985 | - | - | - |
Last Close Price | 21.64 | 21.55 | 10.51 | - | - | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Feb '26 Feb 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | 32.71 | - | - | - | - |
Forward PE | 33.17 | 32.06 | 200.19 | - | - | - |
PS Ratio | 8.42 | 7.58 | 5.99 | - | - | - |
PB Ratio | 21.42 | 12.35 | 13.71 | - | - | - |
P/TBV Ratio | 26.10 | 13.70 | 17.76 | - | - | - |
P/FCF Ratio | 61.83 | 21.71 | - | - | - | - |
P/OCF Ratio | 61.49 | 21.59 | - | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Feb '26 Feb 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 8.33 | 7.38 | 5.83 | - | - | - |
EV/EBITDA Ratio | 766.89 | 122.11 | - | - | - | - |
EV/EBIT Ratio | - | 160.18 | - | - | - | - |
EV/FCF Ratio | 60.25 | 21.15 | - | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Feb '26 Feb 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.21 | 0.21 | 0.50 | 0.41 | -6.20 | 1.85 |
Debt / EBITDA Ratio | 2.05 | 2.05 | - | - | - | - |
Debt / FCF Ratio | 0.37 | 0.37 | - | - | - | - |
Net Debt / Equity Ratio | -0.75 | -0.75 | -0.50 | -0.79 | -1.63 | -0.16 |
Net Debt / EBITDA Ratio | -7.64 | -7.64 | 0.93 | 0.51 | -0.37 | 0.14 |
Net Debt / FCF Ratio | -1.32 | -1.32 | 0.79 | 0.54 | -0.49 | 0.16 |
Asset Turnover | 1.24 | 1.24 | 1.03 | 0.19 | - | - |
Inventory Turnover | 0.70 | 0.70 | 1.00 | - | - | - |
Quick Ratio | 2.83 | 2.83 | 2.21 | 3.18 | 1.77 | 8.99 |
Current Ratio | 3.40 | 3.40 | 2.75 | 3.64 | 1.81 | 9.17 |
Return on Equity (ROE) | 52.77% | 52.77% | -60.44% | -481.35% | -481.49% | -64.30% |
Return on Assets (ROA) | 3.58% | 3.58% | -16.11% | -57.92% | -31.32% | -19.14% |
Return on Invested Capital (ROIC) | 29.79% | 32.42% | -152.06% | -287.98% | -133.15% | -125.94% |
Return on Capital Employed (ROCE) | 6.20% | 6.20% | -36.70% | -107.80% | -123.70% | -37.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Feb '26 Feb 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -0.01% | 3.06% | -4.82% | - | - | - |
FCF Yield | 1.62% | 4.61% | -4.63% | - | - | - |
Buyback Yield / Dilution | -3.42% | -6.19% | -18.67% | -33.41% | -2.66% | -6.54% |